Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2018-07-21 2018-07-20
Drug Identification Number 02258056 02258056
Brand name ARIXTRA ARIXTRA
Common or Proper name Arixtra® 7.5mg Arixtra® 7.5mg
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients FONDAPARINUX SODIUM FONDAPARINUX SODIUM
Strength(s) 12.5MG 12.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 PF syringes 10 PF syringes
ATC code B01AX B01AX
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-12-31 2017-12-31
Actual start date 2017-12-31 2017-12-31
Estimated end date 2018-07-23 2018-07-23
Actual end date 2018-07-20 2018-07-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments